A retrospective review of the associations between amblyopia type, patient age, treatment compliance and referral

Brian E-G Chua1, Kim Johnson, Frank Martin

  • 1Department of Ophthalmology, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Insights

Amblyopia management in children shows that while patching compliance is moderate (around 67%), it is lowest in toddlers aged 15-30 months. Early screening by general practitioners and pediatricians is crucial for preventing vision loss.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Public Health

Background:

  • Amblyopia, or 'lazy eye,' is a leading cause of preventable vision impairment in children.
  • Early detection and intervention are critical for successful amblyopia treatment outcomes.
  • Public hospital clinics without formal screening programs present unique challenges for amblyopia management.

Purpose of the Study:

  • To analyze the characteristics of children with amblyopia attending a public hospital clinic.
  • To evaluate referral sources, presenting ages, and amblyopia types.
  • To assess treatment compliance with patching therapy and identify factors influencing it.

Main Methods:

  • Retrospective review of 127 children diagnosed with amblyopia between January 2001 and May 2003.
  • Analysis of presenting age, amblyopia type, referral source, and patching compliance.
  • Statistical analysis included means, 95% confidence intervals, and Mantel-Haenszel chi2 tests.

Main Results:

  • Most referrals originated from general practitioners and pediatricians.
  • The mean age of presentation was 32.9 months; deprivation amblyopia tended to be identified earliest.
  • Overall patching compliance was approximately 67%, with no significant difference between sexes or amblyopia types, but was lowest in children aged 15-30 months.

Conclusions:

  • Amblyopia is preventable, necessitating a multidisciplinary approach and targeted education for primary care physicians.
  • Teachers can play a role in identifying missed cases.
  • Treatment intensification and individualization are recommended for children aged 15-30 months due to poorer compliance in this age group.
Abstract

Related Concept Videos